• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人结核性脑膜炎的治疗结局:系统评价和荟萃分析。

Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis.

机构信息

Department of Respiratory and Critical Care Medicine West China Hospital, Sichuan University, No. 37, Guo Xue Alley, Chengdu, 610041, China.

Chengdu Medical College, Chengdu, Sichuan Province, People's Republic of China.

出版信息

BMC Pulm Med. 2019 Nov 6;19(1):200. doi: 10.1186/s12890-019-0966-8.

DOI:10.1186/s12890-019-0966-8
PMID:31694599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6833188/
Abstract

BACKGROUND

Tuberculous meningitis is the most devastating presentation of disease with Mycobacterium tuberculosis. We sought to evaluate treatment outcomes for adult patients with this disease.

METHODS

The Ovid MEDLINE, EMBASE, Cochrane Library and Web of Science databases were searched to identify all relevant studies. We pooled appropriate data to estimate treatment outcomes at the end of treatment and follow-up.

RESULTS

Among the articles identified, 22 met our inclusion criteria, with 2437 patients. In a pooled analysis, the risk of death was 24.7% (95%CI: 18.7-31.9). The risk of neurological sequelae among survivors was 50.9% (95%CI: 40.2-61.5). Patients diagnosed in stage III or human immunodeficiency virus (HIV) positive were significantly more likely to die (64.8, 53.4% respectively) during treatment. The frequency of cerebrospinal fluid (CSF) acid-fast-bacilli smear positivity was 10.0% (95% CI 5.5-17.6), 23.8% (15.2-35.3) for CSF culture positivity, and 22.3% (17.8-27.5) for CSF polymerase chain reaction positivity. We found that the headache, fever, vomiting, and abnormal chest radiograph were the most common symptoms and diagnostic findings among tuberculous meningitis patients.

CONCLUSIONS

Despite anti-tuberculosis treatment, adult tuberculous meningitis has very poor outcomes. The mortality rate of patients diagnosed in stage III or HIV co-infection increased significantly during treatment.

摘要

背景

结核性脑膜炎是由结核分枝杆菌引起的最具破坏性的疾病表现。我们试图评估这种疾病的成年患者的治疗结果。

方法

在 Ovid MEDLINE、EMBASE、Cochrane 图书馆和 Web of Science 数据库中搜索所有相关研究。我们汇总了适当的数据,以估计治疗结束时和随访时的治疗结果。

结果

在所确定的文章中,有 22 篇符合纳入标准,共 2437 例患者。在汇总分析中,死亡风险为 24.7%(95%CI:18.7-31.9)。幸存者发生神经后遗症的风险为 50.9%(95%CI:40.2-61.5)。在治疗期间,诊断为 III 期或人类免疫缺陷病毒(HIV)阳性的患者死亡的可能性明显更高(分别为 64.8%和 53.4%)。脑脊液(CSF)抗酸杆菌涂片阳性的频率为 10.0%(95%CI 5.5-17.6),CSF 培养阳性的频率为 23.8%(15.2-35.3),CSF 聚合酶链反应阳性的频率为 22.3%(17.8-27.5)。我们发现头痛、发热、呕吐和异常胸部 X 线是结核性脑膜炎患者最常见的症状和诊断发现。

结论

尽管进行了抗结核治疗,但成人结核性脑膜炎的预后仍很差。在治疗期间,诊断为 III 期或 HIV 合并感染的患者的死亡率显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/fa62385fca73/12890_2019_966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/e611221d46a3/12890_2019_966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/9d2f0107947f/12890_2019_966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/961bb90c2749/12890_2019_966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/fa62385fca73/12890_2019_966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/e611221d46a3/12890_2019_966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/9d2f0107947f/12890_2019_966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/961bb90c2749/12890_2019_966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6833188/fa62385fca73/12890_2019_966_Fig4_HTML.jpg

相似文献

1
Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis.成人结核性脑膜炎的治疗结局:系统评价和荟萃分析。
BMC Pulm Med. 2019 Nov 6;19(1):200. doi: 10.1186/s12890-019-0966-8.
2
Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis.儿童结核性脑膜炎的治疗结局:系统评价和荟萃分析。
Lancet Infect Dis. 2014 Oct;14(10):947-57. doi: 10.1016/S1473-3099(14)70852-7. Epub 2014 Aug 6.
3
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.强化治疗高剂量利福平联合左氧氟沙星与标准治疗成人结核性脑膜炎(TBM-IT)的随机对照试验方案。
Trials. 2011 Feb 2;12:25. doi: 10.1186/1745-6215-12-25.
4
Clinical features, Outcomes and Molecular Profiles of Drug Resistance in Tuberculous Meningitis in non-HIV Patients.非HIV感染患者结核性脑膜炎的临床特征、结局及耐药分子特征
Sci Rep. 2016 Jan 7;6:19072. doi: 10.1038/srep19072.
5
Drug-resistant tuberculous meningitis.耐药性结核性脑膜炎。
Expert Rev Anti Infect Ther. 2013 Jun;11(6):605-21. doi: 10.1586/eri.13.39.
6
Diagnosis of tuberculous meningitis: challenges and promises.结核性脑膜炎的诊断:挑战与前景
Malays J Pathol. 2015 Apr;37(1):1-9.
7
Tuberculous meningitis in patients infected with human immunodeficiency virus.HIV 感染者的结核性脑膜炎。
J Neurol. 2011 Jan;258(1):3-13. doi: 10.1007/s00415-010-5744-8. Epub 2010 Sep 17.
8
Tuberculous meningitis at a large inner-city medical center.大城市中心一家医疗中心的结核性脑膜炎
Am J Med Sci. 1997 Jun;313(6):325-31. doi: 10.1097/00000441-199706000-00002.
9
Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment.治疗结核性脑膜炎期间,预处理脑脊液细菌载量与炎症反应相关,并可预测神经系统事件。
J Infect Dis. 2019 Feb 23;219(6):986-995. doi: 10.1093/infdis/jiy588.
10
Application of the polymerase chain reaction to monitor Mycobacterium tuberculosis DNA in the CSF of patients with tuberculous meningitis after antibiotic treatment.聚合酶链反应在监测结核性脑膜炎患者抗生素治疗后脑脊液中结核分枝杆菌DNA的应用。
J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):175-7. doi: 10.1136/jnnp.59.2.175.

引用本文的文献

1
Anti-TB treatment outcomes in TB meningitis: A systematic review and meta-analysis.结核性脑膜炎的抗结核治疗结果:一项系统评价和荟萃分析。
New Microbes New Infect. 2025 Aug 21;67:101623. doi: 10.1016/j.nmni.2025.101623. eCollection 2025 Oct.
2
Risk Factors for Postoperative Neurologic Dysfunction in Patients with Spinal Tuberculosis: A Retrospective Study.脊柱结核患者术后神经功能障碍的危险因素:一项回顾性研究
Infect Drug Resist. 2025 Jul 25;18:3695-3707. doi: 10.2147/IDR.S528677. eCollection 2025.
3
Influence of HIV co-infection on clinical presentation and disease outcome in hospitalized adults with tuberculous meningitis in Brazil: a nationwide observational study.

本文引用的文献

1
Treatment of Tuberculous Meningitis and Its Complications in Adults.成人结核性脑膜炎及其并发症的治疗
Curr Treat Options Neurol. 2018 Feb 28;20(3):5. doi: 10.1007/s11940-018-0490-9.
2
HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.欧洲移民中的艾滋病毒与结核病合并感染:关于患病率、发病率和死亡率的系统评价
PLoS One. 2017 Sep 28;12(9):e0185526. doi: 10.1371/journal.pone.0185526. eCollection 2017.
3
Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
HIV合并感染对巴西住院成年结核性脑膜炎患者临床表现及疾病转归的影响:一项全国性观察性研究
Front Public Health. 2025 Jun 16;13:1600104. doi: 10.3389/fpubh.2025.1600104. eCollection 2025.
4
A retrospective study on unfavorable 28-day neurological outcomes of stage II TB meningitis.一项关于II期结核性脑膜炎28天不良神经学转归的回顾性研究。
Sci Rep. 2025 May 30;15(1):19003. doi: 10.1038/s41598-025-02708-2.
5
Mortality predictors and diagnostic challenges in adult tuberculous meningitis: a retrospective cohort of 100 patients.成人结核性脑膜炎的死亡率预测因素及诊断挑战:一项针对100例患者的回顾性队列研究
Trop Med Health. 2025 Apr 24;53(1):58. doi: 10.1186/s41182-025-00738-0.
6
Tuberculous Meningitis Across the Lifespan.全生命周期的结核性脑膜炎
J Infect Dis. 2025 Jun 2;231(5):1101-1111. doi: 10.1093/infdis/jiaf181.
7
Optimizing Pyrazinamide Use: A Low-Hanging Fruit in Improving Outcomes with Tuberculous Meningitis? Narrative Review.优化吡嗪酰胺的使用:改善结核性脑膜炎治疗效果的一项易事?叙述性综述
Infect Dis Ther. 2025 Feb;14(2):317-325. doi: 10.1007/s40121-024-01102-1. Epub 2025 Jan 3.
8
Extensive Physiotherapy Rehabilitation for Pulmonary Tuberculosis and Tuberculous Meningitis With Ventriculoperitoneal Shunting: A Case Report.广泛物理治疗康复用于肺结核和结核性脑膜炎伴脑室腹腔分流术:病例报告
Cureus. 2024 Sep 30;16(9):e70578. doi: 10.7759/cureus.70578. eCollection 2024 Sep.
9
Systematic review of tuberculous meningitis in high-risk populations: mortality and diagnostic disparities.高危人群结核性脑膜炎的系统评价:死亡率与诊断差异
Future Microbiol. 2025 May-Jun;20(7-9):559-571. doi: 10.1080/17460913.2024.2366604. Epub 2024 Oct 3.
10
Inside the Brain: Cerebrospinal Fluid Insights in Meningitis.大脑内部:脑膜炎中脑脊液的见解
Cureus. 2024 Aug 16;16(8):e67008. doi: 10.7759/cureus.67008. eCollection 2024 Aug.
临床参数、常规炎症标志物及白三烯A4水解酶(LTA4H)基因型作为印度尼西亚608例结核性脑膜炎患者死亡率的预测指标
J Infect Dis. 2017 Apr 1;215(7):1029-1039. doi: 10.1093/infdis/jix051.
4
Clinical Features and Outcome in Adult Cases of Tuberculous Meningitis in Tertiary Care Hospital in Antananarivo, Madagascar.马达加斯加塔那那利佛三级护理医院成人结核性脑膜炎病例的临床特征与转归
Biomed Res Int. 2017;2017:9316589. doi: 10.1155/2017/9316589. Epub 2017 Mar 15.
5
Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults.华西地区结核性脑膜炎的临床特征、长期临床结局和预后因素:154 例成人的多变量分析。
Expert Rev Anti Infect Ther. 2017 Jun;15(6):629-635. doi: 10.1080/14787210.2017.1309974. Epub 2017 Apr 7.
6
Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies.提高结核性脑膜炎研究质量和可比性的标准化方法。
Clin Infect Dis. 2017 Feb 15;64(4):501-509. doi: 10.1093/cid/ciw757.
7
Six months therapy for tuberculous meningitis.结核性脑膜炎的六个月治疗
Cochrane Database Syst Rev. 2016 Sep 1;9(9):CD012091. doi: 10.1002/14651858.CD012091.pub2.
8
Corticosteroids for managing tuberculous meningitis.用于治疗结核性脑膜炎的皮质类固醇。
Cochrane Database Syst Rev. 2016 Apr 28;4(4):CD002244. doi: 10.1002/14651858.CD002244.pub4.
9
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.成人结核性脑膜炎的强化抗结核治疗。
N Engl J Med. 2016 Jan 14;374(2):124-34. doi: 10.1056/NEJMoa1507062.
10
Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis.矛盾表现常见于HIV阴性结核性脑膜炎。
Medicine (Baltimore). 2016 Jan;95(1):e1997. doi: 10.1097/MD.0000000000001997.